Added to YB: 2021-02-09
Pitch date: 2021-02-09
CLPT [bullish]
ClearPoint Neuro, Inc.
-65.26%
current return
Author Info
Maxwell House shares investing ideas, notes, and research. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$27.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
2# ClearPoint Neuro - Insane in The Brain?
CLPT: Platform for MRI-guided neurosurgery & drug delivery. 25+ biotech partners, no downside risk from trials. Expanding in EU. Strong mgmt, strategic investors. Biologics rev +162% Q3. Only real-time MRI platform. 60+ hospitals, aiming for 80 centers of excellence. Potential $72M DBS market.
Read full article (15 min)